Does sustained hyperglycemia promote red-cell glycation and oxidative injury that reduce deformability and microvascular flow?

Sustained hyperglycemia is biologically capable of altering erythrocyte membrane properties in ways relevant to microcirculatory function. The overall pathway is most firmly supported through cellular and rheologic mechanisms; its contribution to clinical microvascular impairment is likely multifactorial rather than attributable to red cells alone.

Mechanistic and rheologic evidence

• High glucose promotes glycation of erythrocyte membrane and cytoskeletal proteins and increases reactive oxygen species, with oxidative injury to membrane lipids and proteins. These changes provide complementary mechanisms for membrane stiffening.
• In experimental glucose-exposure models, glycation accompanied increased oxidative damage and reduced red-cell deformability. A microfluidic study found reduced deformability after 24 hours of high-glucose exposure and in people with type 2 diabetes.
• Glycation- and oxidation-related changes in membrane surface characteristics and mechanics may also promote erythrocyte aggregation. This is a coherent hemorheologic mechanism, although aggregation is influenced by concurrent glucose exposure, oxidative stress, and other blood-rheology factors.

Microvascular implications

• Less deformable red cells may encounter greater resistance during passage through narrow capillaries; greater aggregation may increase viscosity and impede microcirculatory transit. Together, these abnormalities can plausibly reduce effective capillary flow.
• Clinical observations align with this framework: reduced deformability has been associated with diabetes, poorer glycemic control, and diabetic microvascular complications, including retinopathy and kidney complications. These associations do not establish that red-cell stiffness is the sole cause of those complications.
• Endothelial factors are also important. During short-term in-vivo hyperglycemia, fewer capillaries carried flowing red cells despite no measured change in deformability, with altered endothelial glycocalyx permeability implicated.

Bottom line

• Hyperglycemia-associated erythrocyte glycation, oxidative injury, and reduced deformability are moderately supported; increased aggregation and impaired microvascular flow are credible downstream consequences, but occur within a broader vascular process involving endothelial and glycocalyx dysfunction.